Results
eNauka >
Results >
Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study
| Title: | Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study | Authors  : | Lu, Shun; ...; Petrovic, Marina   ; ...; (broj, koautora 22) |
Issue Date: | 2025 | Publication: | LANCET RESPIRATORY MEDICINE | ISSN: | 2213-2600 Lancet Respiratory Medicine Search Idenfier |
Type: | Article | Collation: | vol. 13 br. 12 str. 1096-1107 | DOI: | 10.1016/S2213-2600(25)00209-7 | WoS-ID: | 001632842400022 | Scopus-ID: | 2-s2.0-105018191471 | URI: | https://enauka.gov.rs/handle/123456789/1015552 | Project: | Incyte | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21a+M21a+ |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.